Sartorius Stedim Biotech has a total of 2308 patents globally, out of which 1281 have been granted. Of these 2308 patents, more than 61% patents are active. Germany is where Sartorius Stedim Biotech has filed the maximum number of patents, followed by USA and Europe. Parallelly, Germany seems to be the main focused R&D center and also is the origin country of Sartorius Stedim Biotech.
Sartorius Stedim Biotech subpart of Sartorius Ag. Sartorius Stedim Biotech develops and manufactures laboratory technologies and equipment for the pharma and food industries, as well as for public research institutes and laboratories. As of July 2022, Sartorius Stedim Biotech has a market cap of $30.77 Billion.
Do read about some of the most popular patents of Sartorius Stedim Biotech which have been covered by us in this article and also you can find Sartorius Stedim Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sartorius Stedim Biotech patent portfolio.
How many patents does Sartorius Stedim Biotech have?
Sartorius Stedim Biotech has a total of 2308 patents globally. These patents belong to 735 unique patent families. Out of 2308 patents, 1429 patents are active.
How Many Patents did Sartorius Stedim Biotech File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Sartorius Stedim Biotech Applications Filed | Sartorius Stedim Biotech Patents Granted |
2011 | 108 | 29 |
2012 | 112 | 54 |
2013 | 87 | 61 |
2014 | 138 | 77 |
2015 | 124 | 77 |
2016 | 174 | 92 |
2017 | 168 | 87 |
2018 | 182 | 91 |
2019 | 144 | 112 |
2020 | 139 | 118 |
2021 | 49 | 107 |
2022 | 4 | 58 |
How many Sartorius Stedim Biotech patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sartorius Stedim Biotech File in Different Countries?
Countries in which Sartorius Stedim Biotech Filed Patents
Country | Patents |
Germany | 556 |
United States Of America | 500 |
Europe | 440 |
China | 145 |
Japan | 77 |
India | 40 |
Korea (South) | 33 |
Austria | 26 |
Denmark | 21 |
United Kingdom | 17 |
Canada | 15 |
Spain | 14 |
Singapore | 10 |
Australia | 10 |
France | 6 |
Israel | 5 |
Hong Kong (S.A.R.) | 5 |
Portugal | 3 |
Switzerland | 2 |
Brazil | 2 |
Norway | 2 |
Hungary | 1 |
Chile | 1 |
Russia | 1 |
South Africa | 1 |
Poland | 1 |
Mexico | 1 |
New Zealand | 1 |
Where are Research Centers of Sartorius Stedim Biotech Patents Located?
10 Best Sartorius Stedim Biotech Patents
US7048775B2 is the most popular patent in the Sartorius Stedim Biotech portfolio. It has received 186 citations so far from companies like Ethicon Llc, Baxter International Inc and Cilag Gmbh International.
Below is the list of 10 most cited patents of Sartorius Stedim Biotech:
Publication Number | Citation Count |
US7048775B2 | 186 |
US6837995B1 | 105 |
US6453683B1 | 95 |
DE202007005868U1 | 66 |
US6684646B2 | 65 |
US20080299652A1 | 63 |
US6623631B1 | 57 |
US6579445B2 | 53 |
USD632799S1 | 52 |
WO2009116002A1 | 46 |
Which Companies are using Sartorius Stedim Biotech Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Sartorius Stedim Biotech patent portfolio are Life Technologies, Emd Millipore Corporation and Ge Healthcare Bio-Sciences Ab.
List of the top forward citing Companies –
Company | Number of Patents |
Life Technologies | 12 |
Emd Millipore Corporation | 8 |
Ge Healthcare Bio-Sciences Ab | 5 |
Praxair | 5 |
Global Life Sciences Solutions Usa Llc | 5 |
Morgan Stanley Senior Funding Inc | 4 |
Eppendorf | 4 |
Apple | 3 |
Fremon Scientific Inc | 3 |
Boeing | 3 |
Count of 102 and 103 Type Rejections based on Sartorius Stedim Biotech Patents
Top Sartorius Stedim Biotech Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US8749396B2 | 23 |
US8982156B2 | 13 |
US8690129B2 | 11 |
US10119108B2 | 11 |
US6684646B2 | 10 |
US6579445B2 | 8 |
US8177123B2 | 8 |
US8426202B2 | 6 |
US8581738B2 | 6 |
US7513127B2 | 6 |
US9199202B2 | 6 |
US9044718B2 | 5 |
US9045722B2 | 5 |
US7425441B2 | 5 |
US6631616B2 | 5 |
What Percentage of Sartorius Stedim Biotech US Patent Applications were Granted?
Sartorius Stedim Biotech (Excluding its subsidiaries) has filed 386 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 292 have been granted leading to a grant rate of 89.5%.
Below are the key stats of Sartorius Stedim Biotech patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Sartorius Stedim Biotech?
Law Firm | Total Applications | Success Rate |
Hespos & Porco Llp | 182 | 90.96% |
Nixon & Vanderhye Pc | 25 | 87.50% |
Dilworth Ip Llc | 23 | 75.00% |
Chernoff Vilhauer Mcclung & Stenzel Llp | 22 | 95.45% |
Klarquist Sparkman Llp | 20 | 80.00% |
Edell Shapiro & Finnan Llc | 15 | 60.00% |
Proskauer Rose Llp | 14 | 100.00% |
Mcdonnell Boehnen Hulbert & Berghoff Llp | 10 | 88.89% |
Sughrue Mion Pllc | 7 | 71.43% |
Crowell & Moring Llp | 6 | 100.00% |
EXCLUSIVE INSIGHTS COMING SOON!